After yesterday’s overall rise, the A-share market adjusted again this morning, and the Shanghai index was close to the integer mark of 3200 points.
The new energy track led the decline, and the leading stock Contemporary Amperex Technology Co.Limited(300750) plunged more than 5%. The company announced this morning that its holding subsidiary invested in the construction of power battery industry chain project in Indonesia.
Today, the popular traditional Chinese medicine stock Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) fell to the limit for a time. Yesterday, Wang Sicong forwarded a message about Lianhua Qingwen Capsule on his microblog and said that the regulatory authorities should strictly investigate Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) . About an hour later, Wang Sicong edited the microblog and deleted the words Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) and others that the regulatory authorities should strictly investigate.
In addition, the leading non-ferrous metal company Zijin Mining Group Company Limited(601899) issued an announcement in the morning in response to its subsidiary’s “unlicensed cross-border mining” Zijin Mining Group Company Limited(601899) a shares fluctuated slightly in the morning and were generally stable. Up to now, Zijin Mining Group Company Limited(601899) market value still exceeds 300 billion yuan.
A-Shares fall into adjustment, and the Shanghai index approaches 3200 points
After rising yesterday, the Shanghai and Shenzhen stock index fell this morning. The Shanghai composite index was adjusted to the integer level of 3200 points again, and the Shenzhen composite index once fell by more than 1%.
In terms of industry sectors, the electrical equipment sector led the decline, with a decline of more than 3%, with Jiangsu Azure Corporation(002245) , Hebei Huatong Wires And Cables Group Co.Ltd(605196) , Tianjin Zhonghuan Semiconductor Co.Ltd(002129) , Jiangsu Goodwe Power Supply Technology Co.Ltd(688390) , Jiangsu Yangdian Science & Technology Co.Ltd(301012) and other stocks leading the decline.
General machinery, culture, education and leisure, warehousing and logistics, chemical fiber, Internet, software services and other sectors also fell by more than 2%.
Real estate, steel, food and beverage and other sectors resisted the decline and rose against the trend.
In terms of concept sector, the biological vaccine concept sector that fell sharply yesterday rebounded, of which Walvax Biotechnology Co.Ltd(300142) rose by more than 9%, and Shanghai Junshi Biosciences Co.Ltd(688180) -u rose by more than 8% Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) intraday increase of more than 4% Chongqing Zhifei Biological Products Co.Ltd(300122) intraday growth was once about 4%.
The previous trading day, affected by relevant news, Chongqing Zhifei Biological Products Co.Ltd(300122) plunged 14.19% and Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) plunged 9.46%.
There were several stocks diving this morning.
Caida Securities Co.Ltd(600906) started a straight-line dive at about 10:50 a.m., and the stock price fell from only about 1% to the limit for a time in about 10 minutes. At the same time, the trading volume expanded rapidly.
Hainan Ruize New Building Material Co.Ltd(002596) this morning, after 10:30, the diving was continuous, and the limit was firmly sealed at about 10:50.
new energy track stocks fell again
Contemporary Amperex Technology Co.Limited(300750) fell more than 5%
In terms of typical tracks, the new energy track was adjusted again, and the leading stock Contemporary Amperex Technology Co.Limited(300750) fell by more than 5%.
Contemporary Amperex Technology Co.Limited(300750) announced this morning that the second meeting of the third board of directors of the company considered and approved the proposal on the investment and construction of power battery industry chain project by holding subsidiaries in Indonesia on April 14, 2022, Ningbo puqin Times Co., Ltd. (hereinafter referred to as “puqin times”), a subsidiary of Guangdong Bangpu Recycling Technology Co., Ltd. (hereinafter referred to as “Guangdong Bangpu”), a holding subsidiary of the company, plans to invest in the construction of power battery industry chain project in Indonesia.
The announcement said that with the promotion of global energy reform, transformation and upgrading and the continuous improvement of carbon emission requirements, the new energy industry has developed rapidly in recent years, and the resources required for global power battery production have increased. In order to ensure the supply of key resources and raw materials in the upstream, the company plans to cooperate with Pt Aneka tambang TBK, (hereinafter referred to as “antam”) and Pt industri baterai Indonesia (hereinafter referred to as “IBI”) jointly invest in the construction of power battery industry chain project in FHT Industrial Park in East hamahela County, North Maluku Province, Indonesia and other relevant industrial parks in Indonesia. At present, the total investment amount of the project is no more than US $5.968 billion or equivalent currency.
Contemporary Amperex Technology Co.Limited(300750) said that the implementation of the project is conducive to further improving the company’s strategic layout in the lithium new energy industry, ensuring the supply of key upstream resources and raw materials, reducing the company’s production costs and promoting the layout of the company’s battery recycling industry. The investment and construction of the project will increase the company’s capital expenditure and cash expenditure, but in the long run, it will have a positive impact on the company’s business layout and operating performance, which is in line with the interests of all shareholders of the company.
In addition to Contemporary Amperex Technology Co.Limited(300750) , many other leaders in the new energy track also fell sharply. As of the morning closing, Tianjin Zhonghuan Semiconductor Co.Ltd(002129) fell 6.60%, Sungrow Power Supply Co.Ltd(300274) fell 5.35%, and Trina Solar Co.Ltd(688599) fell 4.09%.
Zijin Mining Group Company Limited(601899) announcement response to “unlicensed cross-border mining”
.
Zijin Mining Group Company Limited(601899) a shares opened low in the morning, but the subsequent decline was narrowed for a time, and the overall performance was relatively stable.
Zijin Mining Group Company Limited(601899) announced that Zijin Mining Group Company Limited(601899) (hereinafter referred to as “our company” or “the company”) holding subsidiary Ulat Houqi Zijin Mining Group Company Limited(601899) Co., Ltd. (hereinafter referred to as “Ulat Houqi Zijin”) recently reported by the media that there were situations such as unlicensed cross-border mining, which has been filed for investigation by Ulat Houqi Public Security Bureau.
According to the announcement data, Wuhou Zijin was established in 2005, mainly developing sanguikou zinc (lead) mine in wulathou banner, Inner Mongolia. It has the mining license for the south section of sanguikou zinc (lead) mine (the mining area is 2.2797 square kilometers, which is valid from June 6, 2012 to June 6, 2042), and the mining license scale is 10000 tons / day; It has the exploration certificate of the North ore section (obtained in 2005, and has been renewed for many times since then. The latest exploration area is 3.9 square kilometers, which is valid until December 7, 2021. At present, it is applying for exploration and mining procedures). By the end of 2021, sanguikou zinc (lead) mine has 1.75 million tons of zinc metal resources with a grade of 2.38%, and 380000 tons of symbiotic lead metal resources with a grade of 0.54%.
Zijin Mining Group Company Limited(601899) announcement indicates that according to our preliminary understanding, the north and South ore sections of sanguikou zinc (lead) mine are the same ore body, and Wuhou Zijin applied for the mining right of the integration of the north and South ore sections in 2012. Due to the low degree of exploration in the North ore section, only the mining right in the South ore section was obtained; Wuhou Zijin carried out supplementary exploration in the North ore section in 2012. It obtained the record certificate of resource reserves in September 2013 and began to apply for mining rights for many times. Due to mining policies, human factors and other factors, the North ore section has not obtained mining rights. Before 2018, the by-product ore was recovered in the exploration process, and there were situations of exploration instead of mining and some cross-border mining.
In 2021, the ore volume of Wuhou Zijin was 2.78 million tons, the average grade of zinc was 2.17%, and the average grade of lead was 0.57%. The concentrate produced contained 50432 tons of zinc and 10662 tons of lead, realizing a sales revenue of 904.06 million yuan and a net profit of 87.44 million yuan, accounting for 0.4% of the company’s sales revenue and 0.56% of the parent company’s net profit in 2021 respectively; By the end of 2021, the total assets and net assets of Wuhou Zijin were 227499 million yuan and 117888 million yuan, accounting for 1.09% of the total assets and 1.66% of the net assets attributable to the parent company respectively.
Zijin Mining Group Company Limited(601899) announcement said that at present, Wuhou Zijin has been reported to be suspected of illegal mining, wulathou banner Public Security Bureau has filed a case, relevant departments have been involved in the investigation, and the nature and situation of violations need to be confirmed by relevant departments. Our company attaches great importance to this and has instructed Wuhou Zijin to actively cooperate with the judicial authorities or competent departments in the investigation, and comprehensively carry out legal compliance inspection in the ownership enterprises.
Wang Sicong questioned Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) intraday limit
Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) ( Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) ) opened low and went low on the 15th. It fell sharply during the session and once hit the limit. As of the midday closing, the stock fell 6.85%, with a turnover of more than 4.5 billion yuan. Since the beginning of this year, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) share price has a strong trend, hitting a record high of 43.12 yuan in April 12 (after the resumption of rights). As of yesterday’s closing, the cumulative increase of the stock has doubled.
On the news, at 13:08 on April 14, Wang Sicong forwarded a message about Lianhua Qingwen Capsule on his microblog and said that the regulatory authorities should strictly investigate Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) . The statement soon fermented on the Internet.
In response to comments on the Internet, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) soon responded: “For the news on Weibo, please point out the specific problems and sources, and we will answer the specific contents. From clinical trials, to specific experimental data, and then to covid-19 pneumonia diagnosis and treatment plan, including indications and instructions, we have complete evidence and report disclosure. We can’t ask questions at will because of the three words’ Wang Sicong ‘. Just listen to and vote for some comments on the Internet Please screen the investors. “
About an hour later, Wang Sicong edited the microblog and deleted the words Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) and others that the regulatory authorities should strictly investigate.
